Francesc Miro Mur I am a researcher in the lab of "Systemic Autoimmune Diseases" of the VHIR. It is a recent operating team focused in the research of cellular and molecular mechanisms underlying the pathology of autoimmune diseases such as antiphospholipid syndrome. Previously, as an awarded Biomedical Researcher (PERIS-ICS) I studied the role of immune cells in modulating the inflammation during the acute phase of stroke. Instituciones de las que forman parte Investigador postdoctoral Enfermedades Sistémicas Vall Hebron Institut de Recerca LinkedIn Twitter Orcid Email Francesc Miro Mur LinkedIn Twitter Orcid Email Instituciones de las que forman parte Investigador postdoctoral Enfermedades Sistémicas Vall Hebron Institut de Recerca I am a researcher in the lab of "Systemic Autoimmune Diseases" of the VHIR. It is a recent operating team focused in the research of cellular and molecular mechanisms underlying the pathology of autoimmune diseases such as antiphospholipid syndrome. Previously, as an awarded Biomedical Researcher (PERIS-ICS) I studied the role of immune cells in modulating the inflammation during the acute phase of stroke.
As a biochemist and cell biologist I started my career in basic research and sharing time as a biochemist lecturer at Universitat Autònoma de Barcelona. Regulation of cell function and activity by protein phosphorylation were the aims of my research. I moved to Paris to carry out my postdoctoral research career. My first postdoc was at CNRS-CEA to study the cell cycle progression and apoptosis under the control of p53 tumour suppressor.. In my second postdoc at Institut Curie I made a change starting a research career on immunology, looking into cellular and functional interaction between T lymphocytes and dendritic cells. It was during this amazing stage I collaborated with clinicians and saw the benefits of translational research. I spent two years at Cibbim working as a team leader in projects about molecular mechanisms of inflammation driving to senescence and about immunological basis of adverse reactions to bioimplants. At IRB I took the opportunity of doing a project in aminoacyl-tRNA synthetases as infectious agents in amebiasis, and also I turned to neuroimmunology and did research in brain ischemia. 1988-1993 BSc in Biology, speciality Biochemistry. UAB, Barcelona 1992-1993 Undergraduate collaborator, Biochem Dept, UAB 1995 Master Fellow, Laboratoire Cancerogénèse Moléculaire, CNRS-Villejuif, France 1996-1999 Ph.D., Biochem Dept, UAB 2000 Postdoc Researcher, Biochem Dept, Universita di Padova, Italy 2000-2003 Lecturer A3.6, Biochem & Mol Biol, UAB 2001-2003 Postdoc. Researcher, Lab Oncogénèse Moléculaire, CEA-CNRS, France 2003-2006 Postdoc Researcher, Cancer & Immunity Lab, Institut Curie, France 2007-2009 Postdoc Researcher, CIBER-nanomedicine, VHIR, Barcelona 2009-2011 Postdoc Researcher, Gene translation Lab, IRB-Barcelona 2011-2016 Postdoc Researcher, IDIBAPS, Barcelona 2017-2019 PERIS Researcher, Hospital Clinic, Barcelona
Proyectos Ajuts Grups de Recerca (SGR) 2022 IP: Jaume Alijotas Reig Colaboradores: Moisés Labrador Horrillo, Carmen Pilar Simeón i Aznar, Anna Sala Cunill, Roser Solans Laque, Segundo Bujan Rivas, Mar Guilarte Clavero, Vicenç Fonollosa Pla, Fernando Martínez Valle, Victòria Cardona Dahl, Francesc Miro Mur, Alfredo Guillen Del Castillo, Albert Selva O'Callaghan, José Pardos Gea, Laura Donaire Lancharro, Ariadna Anunciacion Llunell Entidad financiadora: Agència Gestió Ajuts Universitaris i de Recerca Financiación: 0.01 Referencia: 2021 SGR 00048 Duración: 01/01/2022 - 30/06/2025 Envejecimiento endotelial y procesos inflamatorios crónicos IP: Francesc Miro Mur Colaboradores: - Entidad financiadora: Fundació de l'Agrupació Mútua Financiación: 15000 Referencia: FAMV/01/2008 Duración: 01/01/2009 - 31/12/2009 Envejecimiento endotelial y sus efectos pleiotrópicos sobre procesos inflamatorios, de la respuesta inmune y angiogénesis IP: Francesc Miro Mur Colaboradores: Jaume Alijotas Reig, Simon Schwartz Navarro Entidad financiadora: Fundación Invest. Médica Mutua Madrileña Financiación: 36000 Referencia: FMMA/05/2008 Duración: 24/09/2008 - 23/09/2011 CIBER: Bioingenieria, biomateriales y nanomedicina IP: - Colaboradores: Ibane Abasolo Olaortua, Manuel López Cano, Jaume Alijotas Reig, Francesc Miro Mur, Eloy Espín Basany, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua Entidad financiadora: CIBER Bioing., Biomateriales y Nanomedicina , BBN Financiación: 480000 Referencia: CB06/01/0012 Duración: 01/01/2007 - 31/12/2010
